267 related articles for article (PubMed ID: 28411859)
1. CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function.
Buchheister S; Buettner M; Basic M; Noack A; Breves G; Buchen B; Keubler LM; Becker C; Bleich A
Am J Pathol; 2017 May; 187(5):1106-1120. PubMed ID: 28411859
[TBL] [Abstract][Full Text] [Related]
2. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
[TBL] [Abstract][Full Text] [Related]
4. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
[TBL] [Abstract][Full Text] [Related]
5. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
6. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis.
Breugelmans T; Van Spaendonk H; De Man JG; De Schepper HU; Jauregui-Amezaga A; Macken E; Lindén SK; Pintelon I; Timmermans JP; De Winter BY; Smet A
J Crohns Colitis; 2020 Jul; 14(7):974-994. PubMed ID: 32003421
[TBL] [Abstract][Full Text] [Related]
7. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin ameliorates intestinal barrier dysfunction in experimental colitis by inhibiting the activation of nuclear factor-kappa B.
Cheng J; Zhang L; Dai W; Mao Y; Li S; Wang J; Li H; Guo C; Fan X
Biochem Biophys Res Commun; 2015 Feb; 458(1):140-7. PubMed ID: 25634696
[TBL] [Abstract][Full Text] [Related]
9. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
Lapointe TK; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases.
Tao Y; Yue M; Lv C; Yun X; Qiao S; Fang Y; Wei Z; Xia Y; Dai Y
FASEB J; 2020 Feb; 34(2):3069-3090. PubMed ID: 31908053
[TBL] [Abstract][Full Text] [Related]
12. Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation.
Yu M; Yang S; Qiu Y; Chen G; Wang W; Xu C; Cai W; Sun L; Xiao W; Yang H
J Gastroenterol; 2015 Nov; 50(11):1103-13. PubMed ID: 25820151
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
[TBL] [Abstract][Full Text] [Related]
14. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
15. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
Woo JK; Choi S; Kang JH; Kim DE; Hurh BS; Jeon JE; Kim SY; Oh SH
BMC Complement Altern Med; 2016 Dec; 16(1):498. PubMed ID: 27912750
[TBL] [Abstract][Full Text] [Related]
16. Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis.
Zhang DK; He FQ; Li TK; Pang XH; Cui DJ; Xie Q; Huang XL; Gan HT
J Pathol; 2010 Oct; 222(2):213-22. PubMed ID: 20632386
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
[TBL] [Abstract][Full Text] [Related]
18. Toll-interacting protein modulates colitis susceptibility in mice.
Maillard MH; Bega H; Uhlig HH; Barnich N; Grandjean T; Chamaillard M; Michetti P; Velin D
Inflamm Bowel Dis; 2014 Apr; 20(4):660-70. PubMed ID: 24572204
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
20. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses.
de Buhr MF; Mähler M; Geffers R; Hansen W; Westendorf AM; Lauber J; Buer J; Schlegelberger B; Hedrich HJ; Bleich A
Physiol Genomics; 2006 May; 25(3):426-34. PubMed ID: 16705022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
